This report contains market size and forecasts of CAS9 Technology in Global, including the following market information:
Global CAS9 Technology Market Size 2024-2030, ($ millions)
The global CAS9 Technology market is projected to reach US$ million by 2029.
We surveyed the CAS9 Technology companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global CAS9 Technology Market, by Type, 2024-2030 ($ millions)
Global CAS9 Technology Market Segment Percentages, by Type
Genome Engineering
Disease Models
Global CAS9 Technology Market, by Application, 2024-2030 ($ millions)
Global CAS9 Technology Market Segment Percentages, by Application
Biotechnology & Pharmaceutical Companies
Academic & Research Institutes
Global CAS9 Technology Market, By Region and Country, 2024-2030 ($ Millions)
Global CAS9 Technology Market Segment Percentages, by region and country
United States
Europe
Asia
China
Rest of World
Competitor Analysis
The report also provides analysis of leading market participants including:
Further, the report presents profiles of competitors in the market, key players include:
Cellecta Inc.
abm Inc.
GenScript
CRISPR Therapeutic
Intellia Therapeutics Inc.
GE Healthcare
Takara Bio Inc.
AstraZeneca
PLC
Merck KGaA
Bio-Rad Laboratories Inc.
Danaher Corporation (Integrated DNA Technologies Inc.)
New England Biolabs
OriGene Technologies Inc.
Lonza Group
Thermo Fisher Scientific
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 CAS9 Technology Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global CAS9 Technology Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global CAS9 Technology Overall Market Size
2.1 Global CAS9 Technology Market Size: 2023 VS 2030
2.2 Global CAS9 Technology Market Size, Prospects & Forecasts: 2023-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Key CAS9 Technology Players in Global Market
3.2 Global Companies CAS9 Technology Product & Technology
4 CAS9 Technology Companies Profiles
4.1 Cellecta Inc.
4.1.1 Cellecta Inc. Company Summary
4.1.2 Cellecta Inc. Business Overview
4.1.3 Cellecta Inc. CAS9 Technology Product Offerings & Technology
4.1.4 Cellecta Inc. CAS9 Technology R&D, and Plans
4.2 abm Inc.
4.2.1 abm Inc. Company Summary
4.2.2 abm Inc. Business Overview
4.2.3 abm Inc. CAS9 Technology Product Offerings & Technology
4.2.4 abm Inc. CAS9 Technology R&D, and Plans
4.3 GenScript
4.3.1 GenScript Company Summary
4.3.2 GenScript Business Overview
4.3.3 GenScript CAS9 Technology Product Offerings & Technology
4.3.4 GenScript CAS9 Technology R&D, and Plans
4.4 CRISPR Therapeutic
4.4.1 CRISPR Therapeutic Company Summary
4.4.2 CRISPR Therapeutic Business Overview
4.4.3 CRISPR Therapeutic CAS9 Technology Product Offerings & Technology
4.4.4 CRISPR Therapeutic CAS9 Technology R&D, and Plans
4.5 Intellia Therapeutics Inc.
4.5.1 Intellia Therapeutics Inc. Company Summary
4.5.2 Intellia Therapeutics Inc. Business Overview
4.5.3 Intellia Therapeutics Inc. CAS9 Technology Product Offerings & Technology
4.5.4 Intellia Therapeutics Inc. CAS9 Technology R&D, and Plans
4.6 GE Healthcare
4.6.1 GE Healthcare Company Summary
4.6.2 GE Healthcare Business Overview
4.6.3 GE Healthcare CAS9 Technology Product Offerings & Technology
4.6.4 GE Healthcare CAS9 Technology R&D, and Plans
4.7 Takara Bio Inc.
4.7.1 Takara Bio Inc. Company Summary
4.7.2 Takara Bio Inc. Business Overview
4.7.3 Takara Bio Inc. CAS9 Technology Product Offerings & Technology
4.7.4 Takara Bio Inc. CAS9 Technology R&D, and Plans
4.8 AstraZeneca
4.8.1 AstraZeneca Company Summary
4.8.2 AstraZeneca Business Overview
4.8.3 AstraZeneca CAS9 Technology Product Offerings & Technology
4.8.4 AstraZeneca CAS9 Technology R&D, and Plans
4.9 PLC
4.9.1 PLC Company Summary
4.9.2 PLC Business Overview
4.9.3 PLC CAS9 Technology Product Offerings & Technology
4.9.4 PLC CAS9 Technology R&D, and Plans
4.10 Merck KGaA
4.10.1 Merck KGaA Company Summary
4.10.2 Merck KGaA Business Overview
4.10.3 Merck KGaA CAS9 Technology Product Offerings & Technology
4.10.4 Merck KGaA CAS9 Technology R&D, and Plans
4.11 Bio-Rad Laboratories Inc.
4.11.1 Bio-Rad Laboratories Inc. Company Summary
4.11.2 Bio-Rad Laboratories Inc. Business Overview
4.11.3 Bio-Rad Laboratories Inc. CAS9 Technology Product Offerings & Technology
4.11.4 Bio-Rad Laboratories Inc. CAS9 Technology R&D, and Plans
4.12 Danaher Corporation (Integrated DNA Technologies Inc.)
4.12.1 Danaher Corporation (Integrated DNA Technologies Inc.) Company Summary
4.12.2 Danaher Corporation (Integrated DNA Technologies Inc.) Business Overview
4.12.3 Danaher Corporation (Integrated DNA Technologies Inc.) CAS9 Technology Product Offerings & Technology
4.12.4 Danaher Corporation (Integrated DNA Technologies Inc.) CAS9 Technology R&D, and Plans
4.13 New England Biolabs
4.13.1 New England Biolabs Company Summary
4.13.2 New England Biolabs Business Overview
4.13.3 New England Biolabs CAS9 Technology Product Offerings & Technology
4.13.4 New England Biolabs CAS9 Technology R&D, and Plans
4.14 OriGene Technologies Inc.
4.14.1 OriGene Technologies Inc. Company Summary
4.14.2 OriGene Technologies Inc. Business Overview
4.14.3 OriGene Technologies Inc. CAS9 Technology Product Offerings & Technology
4.14.4 OriGene Technologies Inc. CAS9 Technology R&D, and Plans
4.15 Lonza Group
4.15.1 Lonza Group Company Summary
4.15.2 Lonza Group Business Overview
4.15.3 Lonza Group CAS9 Technology Product Offerings & Technology
4.15.4 Lonza Group CAS9 Technology R&D, and Plans
4.16 Thermo Fisher Scientific
4.16.1 Thermo Fisher Scientific Company Summary
4.16.2 Thermo Fisher Scientific Business Overview
4.16.3 Thermo Fisher Scientific CAS9 Technology Product Offerings & Technology
4.16.4 Thermo Fisher Scientific CAS9 Technology R&D, and Plans
5 Sights by Region
5.1 By Region - Global CAS9 Technology Market Size, 2024 & 2030
5.2 By Region - Global CAS9 Technology Revenue, (2024-2030)
5.3 United States
5.3.1 Key Players of CAS9 Technology in United States
5.3.2 United States CAS9 Technology Development Current Situation and Forecast
5.4 Europe
5.4.1 Key Players of CAS9 Technology in Europe
5.4.2 Europe CAS9 Technology Development Current Situation and Forecast
5.5 China
5.5.1 Key Players of CAS9 Technology in China
5.5.2 China CAS9 Technology Development Current Situation and Forecast
5.6 Rest of World
6 Sights by Product
6.1 By Type - Global CAS9 Technology Market Size Markets, 2024 & 2030
6.2 Genome Engineering
6.3 Disease Models
7 Sights by Application
7.1 By Application - Global CAS9 Technology Market Size, 2024 & 2030
7.2 Biotechnology & Pharmaceutical Companies
7.3 Academic & Research Institutes
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. CAS9 Technology Market Opportunities & Trends in Global Market
Table 2. CAS9 Technology Market Drivers in Global Market
Table 3. CAS9 Technology Market Restraints in Global Market
Table 4. Key Players of CAS9 Technology in Global Market
Table 5. Global Companies CAS9 Technology Product & Technology
Table 6. Cellecta Inc. Company Summary
Table 7. Cellecta Inc. CAS9 Technology Product Offerings
Table 8. abm Inc. Company Summary
Table 9. abm Inc. CAS9 Technology Product Offerings
Table 10. GenScript Company Summary
Table 11. GenScript CAS9 Technology Product Offerings
Table 12. CRISPR Therapeutic Company Summary
Table 13. CRISPR Therapeutic CAS9 Technology Product Offerings
Table 14. Intellia Therapeutics Inc. Company Summary
Table 15. Intellia Therapeutics Inc. CAS9 Technology Product Offerings
Table 16. GE Healthcare Company Summary
Table 17. GE Healthcare CAS9 Technology Product Offerings
Table 18. Takara Bio Inc. Company Summary
Table 19. Takara Bio Inc. CAS9 Technology Product Offerings
Table 20. AstraZeneca Company Summary
Table 21. AstraZeneca CAS9 Technology Product Offerings
Table 22. PLC Company Summary
Table 23. PLC CAS9 Technology Product Offerings
Table 24. Merck KGaA Company Summary
Table 25. Merck KGaA CAS9 Technology Product Offerings
Table 26. Bio-Rad Laboratories Inc. Company Summary
Table 27. Bio-Rad Laboratories Inc. CAS9 Technology Product Offerings
Table 28. Danaher Corporation (Integrated DNA Technologies Inc.) Company Summary
Table 29. Danaher Corporation (Integrated DNA Technologies Inc.) CAS9 Technology Product Offerings
Table 30. New England Biolabs Company Summary
Table 31. New England Biolabs CAS9 Technology Product Offerings
Table 32. OriGene Technologies Inc. Company Summary
Table 33. OriGene Technologies Inc. CAS9 Technology Product Offerings
Table 34. Lonza Group Company Summary
Table 35. Lonza Group CAS9 Technology Product Offerings
Table 36. Thermo Fisher Scientific Company Summary
Table 37. Thermo Fisher Scientific CAS9 Technology Product Offerings
Table 38. By Region? Global CAS9 Technology Revenue, (US$, Mn), 2024 & 2030
Table 39. By Region - Global CAS9 Technology Revenue, (US$, Mn), 2024-2030
Table 40. By Type ? Global CAS9 Technology Market Size, (US$, Mn), 2024 & 2030
Table 41. By Application? Global CAS9 Technology Market Size, (US$, Mn), 2024 & 2030
List of Figures
Figure 1. CAS9 Technology Segment by Type in 2030
Figure 2. CAS9 Technology Segment by Application in 2030
Figure 3. Global CAS9 Technology Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global CAS9 Technology Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global CAS9 Technology Revenue, 2017-2028 (US$, Mn)
Figure 7. By Region - Global CAS9 Technology Revenue Market Share, 2024-2030
Figure 8. By Type - Global CAS9 Technology Revenue Market Share, 2024-2030
Figure 9. By Application - Global CAS9 Technology Revenue Market Share, 2024-2030
